Mechanism-Based Inactivation of Cytochromes P450 2E1 and 2E1 T303A by tert-Butyl Acetylenes: Characterization of Reactive Intermediate Adducts to the Heme and Apoprotein
- 14 November 2002
- journal article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 15 (12) , 1561-1571
- https://doi.org/10.1021/tx020052x
Abstract
The kinetics for the inactivation of cytochrome P450 2E1 and the mutant P450 2E1 T303A by tert-butyl acetylene (tBA) and tert-butyl 1-methyl-2-propynyl ether (tBMP) were investigated. The two acetylenes inactivated the 7-ethoxy-4-(trifluoromethyl)coumarin (7-EFC) O-deethylation activity of purified rabbit P450s 2E1 and 2E1 T303A in a reconstituted system in a time-, concentration-, and NADPH-dependent manner. The KI values for the inactivation of P450s 2E1 and 2E1 T303A by tBA were 1.0 and 2.0 mM, the kinact values were 0.20 and 0.38 min-1, and the t1/2 values were 3.5 and 1.8 min, respectively. The KI values for the tBMP-inactivated P450s were 0.1 and 1.0 mM, the kinact values were 0.12 and 0.07 min-1, and the t1/2 values were 5.9 and 10.2 min, respectively. Losses in enzyme activity occurred with concurrent losses in the P450 CO spectrum and P450 heme, which were accompanied by the appearance of two different tBA- or tBMP-modified heme products in each inactivated sample. LC-MS analysis of the adducts showed masses of 661 or 705 Da, consistent with the mass of an iron-depleted heme plus the masses of a tBA or tBMP reactive intermediate and one oxygen atom, respectively. Only the tBA-inactivated P450 2E1 revealed a tBA-adducted apoprotein with an increase in mass of 99 Da, corresponding to the mass of tBA plus one oxygen atom. Surprisingly, the inactivation, CO spectral and heme loss, and heme adduct formation of the tBA-inactivated T303A mutant were completely reversible after dialysis. In addition, metabolism of para-nitrophenol was not compromised by the tBA-inactivated T303A mutant. Therefore, our studies on the inactivation of P450s 2E1 and 2E1 T303A by tBA and tBMP suggest the existence of three distinct mechanisms for inactivation, among which includes a novel, reversible heme alkylation that has not been previously described with P450 enzymes.Keywords
This publication has 10 references indexed in Scilit:
- High-resolution crystal structure of cytochrome P450camPublished by Elsevier ,2005
- Covalent Alteration of the CYP3A4 Active Site: Evidence for Multiple Substrate Binding DomainsArchives of Biochemistry and Biophysics, 2001
- Differential Effects of Naturally Occurring Isothiocyanates on the Activities of Cytochrome P450 2E1 and the Mutant P450 2E1 T303AArchives of Biochemistry and Biophysics, 2001
- Mammalian Microsomal Cytochrome P450 MonooxygenaseMolecular Cell, 2000
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Crystal structure and refinement of cytochrome P450terp at 2·3 Å resolutionJournal of Molecular Biology, 1994
- Structure and absolute stereochemistry of the four N-phenylprotoporphyrin IX regioisomers isolated from phenylhydrazine-treated myoglobinJournal of the American Chemical Society, 1991
- Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intakeEuropean Journal of Clinical Investigation, 1989
- Cytochrome P-450Published by Springer Nature ,1986
- Alkylation of the prosthetic heme in cytochrome P-450 during oxidative metabolism of the sedative-hypnotic ethchlorvynolJournal of Medicinal Chemistry, 1982